Please assess the completion status of the following clinical trial:

Trial Title: Influence of Oxytocin on Approach-avoidance Tendencies to Social and Non-social Stimuli

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* right-handed~* male~* age between 18 and 35~* Normal or adjusted-to-normal vision (with lenses only)~* Dutch as mother tongue~Exclusion Criteria:~* female~* age below 18 or above 35~* neurological or psychiatric condition (e.g. epilepsy, stroke, concussion), (e.g. anxiety disorder, depression)~* use of psychotropic medication (e.g. anxiolytics, antidepressants)

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- Oxytocin (Type: EXPERIMENTAL): Syntocinon nasal spray (40 IU/ml; oxytocin, product code RVG 03716); single intranasal dose of 24 international units (IU; 3 puffs of 4 IU per nostril)
- Placebo (Type: PLACEBO_COMPARATOR): Saline natriumchloride solution nasal spray; single intranasal dose (3 puffs per nostril)

Based on this trial design, predict the completion outcome and termination type (if applicable).